Dapagliflozina + Metformina Krka

Dapagliflozina + Metformina Krka combines two oral diabetes medications for blood sugar management. This fixed-dose combination is designed to support glycemic control in adults with type 2 diabetes.

Dapagliflozina + Metformina Krka is used to help manage blood sugar levels in adults with type 2 diabetes. This combination therapy works by addressing insulin resistance and promoting glucose excretion, making it a versatile option for those requiring dual-action treatment. It is often prescribed when diet and exercise alone are not sufficient to control blood sugar levels.

Common effects of Dapagliflozina + Metformina Krka may include increased urination, which is a result of the glucose excretion process. Some users may also experience gastrointestinal discomfort, such as nausea or diarrhea, particularly when starting the medication. These effects are generally mild and temporary as the body adjusts to the treatment.

It is important to use Dapagliflozina + Metformina Krka as directed by a healthcare provider. Patients should stay hydrated and monitor for signs of dehydration, especially during physical activity or in hot weather. Regular blood sugar monitoring is recommended to ensure the medication is working effectively.

Dapagliflozina + Metformina Krka may interact with certain medications, including diuretics, insulin, and other diabetes drugs. Alcohol consumption should be limited, as it can affect blood sugar levels and increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.